In this video, Dr. Kenneth Ellenbogen talks about important information presented at the American Heart Association Scientific Sessions 2010. First he talked about the ROCKET AF clinical trial of rivaroxaban, a new drug that is an alternative to warfarin (Coumadin), as well as another alternative, the recently-approved dabigatran. He provided scenarios as to how these drugs …
Read More
StopAfib.org has published the 2010 Most Popular Atrial Fibrillation News Stories and Videos List. Stroke prevention topped the list and included stories about warfarin (Coumadin) and alternatives such as dabigatran (Pradaxa) and rivaroxaban (Xarelto). Other popular topics included the new European atrial fibrillation guidelines, new antiarrhythmic medications, updates on catheter ablation and afib surgery, and …
Read More
On the heels of the US FDA approving dabigatran, the long-awaited alternative to Coumadin (warfarin), comes word that Health Canada has as well. In Canada, dabigatran is known as PRADAX™. Because this is the first alternative to warfarin in Canada, it is big news for the afib community there. Learn more at: Health Canada Approves …
Read More
The long-awaited alternative to Coumadin (warfarin) has just been approved by the US FDA. The FDA just approved Pradaxa (dabigatran) for use by those with atrial fibrillation for preventing afib-related strokes. The FDA based approval on results of the RE-LY trial, which saw patients on Pradaxa having fewer strokes than those on warfarin. And Pradaxa …
Read More
An FDA panel today unanimously recommended that the FDA approve dabigatran (Pradaxa) for reducing the risk of afib strokes. FDA approval is expected quickly, making this the first alternative to warfarin approved in the United States, and also the first atrial fibrillation approval for dabigatran. It is approved in over 70 countries for venous thromboembolisms …
Read More
Next Monday, September 20, 2010, StopAfib.org will be covering the FDA's hearing on dabigatran (Pradaxa), the new alternative to warfarin, and will be "live-tweeting" from the hearing. Get first reports as they happen by following @stopafib on Twitter. If you're already on Twitter, just follow us from the toolbar at the bottom of this page. …
Read More
There is a lot of big news coming out of the European Society of Cardiology (ESC) going on in Barcelona right now. Judging by attendance, this is probably the biggest cardiology event in the world. The big announcement for atrial fibrillation sufferers is the progress towards a replacement for Coumadin (warfarin) coming out of the …
Read More
Dr. Manish Shah talks about Dabigatran and Rivaroxaban, new drugs in clinicals trials to replace the blood thinner Coumadin® (warfarin), an anticoagulant frequently used to avoid strokes by those with atrial fibrillation. He talks about the two categories of these new drugs, thrombin inhibitors and Factor Xa (10a) inhibitors. Dr. …
Read More
If you're on Coumadin or warfarin for your atrial fibrillation, you're probably interested in the coming replacements for it. In part 2 of our Coumadin series, Dr. Manish Shah, Electrophysiologist at Washington Hospital Center in Washington, DC, talks about the clotting cascade and two drugs that are potential replacements for Coumadin. See the video at: …
Read More